BIO

Bio-Rad Laboratories, Inc.Class A

$305.46 -2.25%

Share classes & related securities

BIO is the same company as:

BIO-B

Recent alerts on BIO

All signals →

News S&P 500 Shake-Up: New Entrants Driving Market Momentum

News Why Elliott Sees Hidden Billions Inside Bio-Rad Laboratories

News AM Markets Need to Know: Elliott and Bio-Rad, Ebola outbreak, and more

News Elliott builds big stake in life-science firm Bio-Rad Labs, WSJ reports

Insider trade Sale by Eva Anette Engelhardt (EVP, President, CDG)

News Stock Market Today: Apple Earnings Power S&P 500, Nasdaq To Records; Trump Hits EU

News Bio-Rad outlines 2026 currency-neutral revenue growth of -3% to +0.5% amid Middle East disruption

News Bio-Rad outlines 2026 margin expansion and 0.5%-1.5% revenue growth guidance amid operational improvements

News Qiagen Explores Possible Sale After New Buyer Talks: Report

News Antibody Optimization Service (Affinity Maturation, Humanization, Phage Display, AI-based Computational Optimization) Market Trends Analysis and Growth Forecast Report 2025-2033

News Custom Antibody Market to Reach USD 1,297.65 Million by 2033, Growing Demand for Precision Medicine and Targeted Therapies to Drive the Market – SNS Insider

Scanner Unusual volume (z=3.4)

Scanner Unusual volume (z=3.5)

Scanner Unusual volume (z=3.5)

Scanner Unusual volume (z=3.5)

Get push alerts for BIO

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS